Thyroglobulin Antibodies (TgAb) Test
The thyroglobulin antibodies (TgAb) test detects autoantibodies against thyroglobulin, serving as a marker of autoimmune thyroid disease such as Hashimoto's thyroiditis and as an essential accompaniment to serum thyroglobulin in differentiated thyroid cancer surveillance. TgAb positivity can falsely lower thyroglobulin results, so the two must be measured together.
1
Biomarkers
Blood (serum)
Sample
1–3 business days
Turnaround
No
Fasting
What is the Thyroglobulin Abs test?
The Thyroglobulin Antibodies Test detects autoantibodies against thyroglobulin, serving both as a marker of autoimmune thyroid disease and as an essential accompaniment to serum thyroglobulin measurement in thyroid cancer surveillance. Its dual role makes it relevant in autoimmune thyroid assessment and in oncological follow-up. Within autoimmune thyroid assessment, TgAb are usually measured with TPO antibodies; TPO antibodies are the more sensitive marker for Hashimoto's thyroiditis, but TgAb add value, particularly when TPO antibodies are negative despite clinical suspicion. In differentiated thyroid cancer follow-up, TgAb must be measured alongside serum thyroglobulin because antibody interference can falsely lower the thyroglobulin result, masking residual or recurrent disease; in this context, the TgAb trend itself can act as a surrogate tumour marker. The test is interpreted with thyroid function, TPO antibodies, and, where relevant, the thyroglobulin result and clinical setting.
What does the Thyroglobulin Abs test measure?
Thyroglobulin antibodies are autoantibodies directed against thyroglobulin, the large glycoprotein synthesised by thyroid follicular cells that serves as the matrix for thyroid hormone production. Their presence indicates an autoimmune response to thyroid tissue. TgAb are produced by infiltrating lymphocytes in autoimmune thyroid disease and, beyond their diagnostic role, are clinically important because they interfere with the measurement of serum thyroglobulin used in thyroid cancer surveillance.
TgAb are measured chiefly in two settings: as a marker of autoimmune thyroid disease, particularly Hashimoto's thyroiditis (usually alongside TPO antibodies), and as a mandatory accompaniment to serum thyroglobulin measurement in differentiated thyroid cancer follow-up, where their presence can render the thyroglobulin result unreliable. They are less sensitive than TPO antibodies for autoimmune thyroiditis but add diagnostic value and are essential context for thyroglobulin interpretation.
Why is the Thyroglobulin Abs test ordered?
- Assessment of suspected autoimmune thyroid disease, particularly Hashimoto's thyroiditis, usually alongside TPO antibodies
- Evaluation of autoimmune thyroiditis where TPO antibodies are negative but clinical suspicion remains
- Mandatory measurement alongside serum thyroglobulin in differentiated thyroid cancer surveillance, to detect antibody interference
- Monitoring of the TgAb trend as a surrogate marker in thyroglobulin-antibody-positive thyroid cancer follow-up
- Investigation of unexplained hypothyroidism to establish an autoimmune aetiology
- Assessment of thyroid autoimmunity in patients with other autoimmune conditions or relevant family history
- Evaluation of thyroid status in pregnancy or preconception where autoimmune thyroid disease affects management
Sample collection and turnaround
Sample type
Blood (serum)
Fasting required
No
Collection method
Venipuncture at patient service centre
Turnaround
1–3 business days
Collection notes
No special preparation required. In thyroid cancer surveillance, measure TgAb on the same specimen and assay as serum thyroglobulin. Document recent thyroid surgery or radioiodine and pregnancy status, and use the same assay for serial monitoring.
Specimen requirements
Minimum 0.5 mL serum. Separate serum from cells per Access Medical Laboratories protocol. Specimen stable refrigerated; follow Access Medical Laboratories transport guidelines.
What can affect Thyroglobulin Abs results?
TgAb assays differ substantially in calibration and cut-offs and are not interchangeable, so results and the threshold for positivity should be interpreted against the performing laboratory's method, and serial monitoring should use the same assay.
Detectable TgAb occur in a proportion of the general population without thyroid disease, increasing with age and in women, so a low-titre positive result is not necessarily clinically significant in isolation.
TgAb positivity is more common in patients with other organ-specific autoimmune conditions, reflecting a shared autoimmune predisposition rather than necessarily active thyroid disease.
Release of thyroid antigens after surgery or radioiodine ablation can transiently alter antibody levels, so timing relative to such interventions should be considered in cancer follow-up.
Immune modulation in pregnancy generally lowers thyroid autoantibody titres through gestation, with a rebound postpartum, which should be accounted for when interpreting serial results.
The principal clinical interference runs the other way: when TgAb are present, they interfere with serum thyroglobulin measurement, typically lowering it and risking a falsely reassuring result in cancer surveillance.
What do Thyroglobulin Abs results mean?
Elevated
A positive TgAb supports autoimmune thyroid disease, most often Hashimoto's thyroiditis, especially when accompanied by TPO antibodies and biochemical hypothyroidism. In thyroid cancer follow-up, a positive TgAb signals that the serum thyroglobulin result may be unreliable, and the antibody trend is then monitored as a surrogate for disease status.
Normal
An undetectable TgAb makes thyroglobulin-antibody interference unlikely and, in the autoimmune context, is interpreted alongside TPO antibodies and thyroid function. Low-titre positivity may occur in healthy individuals and is not diagnostic in isolation.
Reduced
A negative or undetectable TgAb is the expected normal. In thyroid cancer surveillance, a negative TgAb supports the reliability of the accompanying thyroglobulin measurement. A negative TgAb does not exclude autoimmune thyroiditis, since TPO antibodies are more sensitive.
Note: TgAb assays are highly method-dependent and not interchangeable, so serial monitoring must use the same assay. Low-level positivity occurs in healthy people, particularly older women. The most important clinical caveat is in thyroid cancer surveillance, where TgAb positivity undermines the reliability of serum thyroglobulin and mandates that the two are always measured together.
Frequently asked questions
It detects autoantibodies against thyroglobulin, a thyroid protein. The test is used both as a marker of autoimmune thyroid disease and as an essential accompaniment to serum thyroglobulin in thyroid cancer surveillance.
How to access the Thyroglobulin Abs test
The Thyroglobulin Abs reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: June 2, 2026
Last reviewed: June 2, 2026
- Haugen BR, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. (2016)
- Spencer CA. Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers. J Clin Endocrinol Metab. (2011)
- Caturegli P, et al. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. (2014)
- Pearce EN, et al. Thyroiditis. N Engl J Med. (2003)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.
Related tests
thyroid endocrine
TSH
The TSH test measures Thyroid Stimulating Hormone produced by the anterior pituitary gland. It is the recommended first-line screening test for thyroid dysfunction, with elevated TSH indicating primary hypothyroidism and suppressed TSH indicating hyperthyroidism. TSH alone does not assess T4-to-T3 conversion or exclude central hypothyroidism.
thyroid endocrine
Free T4
The Free T4 test measures free thyroxine, the unbound and metabolically available fraction of T4, in serum. Interpreted alongside TSH, it confirms and localises thyroid dysfunction — diagnosing primary and central hypothyroidism, grading hyperthyroidism, and monitoring levothyroxine therapy. Free T4 has replaced Total T4 in routine practice because it is unaffected by binding-protein changes.